Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Holmes, Frankie A. Moy, Beverly Delaloge, Suzette Chia, Stephen K.L. Ejlertsen, Bent Mansi, Janine Iwata, Hiroji Gnant, Michael Buyse, Marc Barrios, Carlos H. Silovski, Tajana Šeparović, Robert Bashford, Anna Zotano, Angel Guerrero Denduluri, Neelima Patt, Debra Gokmen, Erhan Gore, Ira Smith II, John W. Loibl, Sibylle Masuda, Norikazu Tomašević, Zorica Petráková, Katarina DiPrimeo, Daniel Wong, Alvin Martin, Miguel Chan, Arlene